10 results on '"Huang, Xiangbo"'
Search Results
2. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population
- Author
-
Zeng, Zhenzhen, Tu, Jing, Cheng, Jin, Yao, Mingjie, Wu, Yali, Huang, Xiangbo, Xie, Xiaomeng, Zhang, Xiaolei, Lu, Fengmin, and Chen, Xiangmei
- Published
- 2015
- Full Text
- View/download PDF
3. Application of single-cell real-time imaging flow cytometry in rapid detection of pathogenic fungi in clinical liquid specimens.
- Author
-
Lv, Linting, Dong, Li, Zheng, Jiajia, Maermaer, Tuohutaerbieke, Huang, Xiangbo, Fan, Xueying, Zhang, Hao, and Shen, Tao
- Published
- 2021
- Full Text
- View/download PDF
4. Circular RNA Hsa_circ_0004018 Inhibits Wnt/β-Catenin Signaling Pathway by Targeting microRNA-626/DKK3 in Hepatocellular Carcinoma.
- Author
-
Zhu, Pengfei, Liang, Han, Huang, Xiangbo, Zeng, Qinglei, Liu, Yanmin, Lv, Jun, and Ming, Liang
- Subjects
CIRCULAR RNA ,HEPATOCELLULAR carcinoma ,POLYMERASE chain reaction ,LIVER cells ,CELL migration - Abstract
Background and Aim: Dysexpression of circular RNAs has been identified in multiple types of cancer. Hsa_circ_0004018 was reported to be significantly downregulated in hepatocellular carcinoma (HCC) and to display HCC-stage-specific expression features. However, the role of hsa_circ_0004018 in HCC progression remains unclear. Methods: The expression of hsa_circ_0004018 or microRNA-626 (miR-626) was detected in tumor tissues and paired non-tumor tissues from HCC patients, as well as in one normal human liver cell line and 5 HCC cell lines by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, dye exclusion assay, clonogenic assay, scratch migration assay and transwell assay were used to measure cell proliferation and migration capacity, respectively. Luciferase report assay and RNA pull down assay were performed to explore the regulatory effect of certain molecules on the expression of target genes. Results: We found that the expression of hsa_circ_0004018 was lower in tumor tissues than in their paired non-tumor tissues from 28 out of 41 HCC patients. The difference in the expression between tumor tissues and non-tumor tissues was statistically significant (p< 0.001). Further analysis revealed that such lower expression in tumor tissues was much more common in bigger tumor size group (≥ 5cm) compared with the smaller tumor size group (< 5cm) (85% vs 42%, p=0.0007). Similarly, hsa_circ_0004018 was downregulated in HCC cell lines. Additionally, a negative correlation between hsa_circ_0004018 and miR-626 expression was noticed in HCC tissues. Moreover, we observed that hsa_circ_0004018 interacted with miR-626/DKK3 and contributed to HCC cell proliferation and migration through inhibiting Wnt/β-catenin signaling pathway in vitro. Furthermore, hsa_circ_0004018 blocked xenograft tumor growth in vivo through inhibiting Wnt/β-catenin signaling pathway by targeting miR-626/DKK3. Conclusion: We revealed that hsa_circ_0004018/miR-626/DKK3 regulatory axis may be a possible novel therapeutic target for HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Traceability, reproducibility and clinical evaluation of Sansure Realtime HCV RNA assay.
- Author
-
Xiangbo Huang, Zhongping Deng, Lu Long, Jinjun Chen, Deming Tan, Liyan Zhu, Xueying Fan, Tao Shen, Fengmin Lu, Huang, Xiangbo, Deng, Zhongping, Long, Lu, Chen, Jinjun, Tan, Deming, Zhu, Liyan, Fan, Xueying, Shen, Tao, and Lu, Fengmin
- Subjects
HEPATITIS C virus ,RNA ,ANTICOAGULANTS ,VIROLOGY ,FOLLOW-up studies (Medicine) ,COMPARATIVE studies ,DIAGNOSTIC reagents & test kits ,HEPATITIS viruses ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,RESEARCH evaluation ,EVALUATION research ,CHRONIC hepatitis C ,ROUTINE diagnostic tests ,GENOTYPES - Abstract
Background: Accurate quantitative detection of hepatitis C virus (HCV) RNA is critical for diagnosis of acute or chronic HCV infection, and for follow-up of virologic response during HCV targeted therapy. In the present study, traceability and reproducibility of a novel China-certified domestic Sansure HCV RNA diagnostic assay (Sansure, Changsha, Hunan, China) was evaluated and the clinical performance of this assay was also analyzed.Methods: Traceability of the Sansure HCV RNA assay to the WHO international standard for HCV (genotype 1a) was detected across multiple centers. Reproducibility, accuracy (the differences of observed average concentrations and expected concentrations) and precision were assessed using series dilutions of World HCV RNA performance panel WWHV303-02 (HCV-1b), WWHV303-04(HCV-2a), WWHV303-11(HCV-3a) and WWHV303-19 (HCV-6a). In addition, both Sansure HCV RNA and CAP/CTM HCV (Roche, Branchburg, NJ, USA) assays were used to detect HCV RNA in 346 EDTA anti-coagulated plasma samples from previous HCV-infected patients, during and after antiviral therapy.Results: The Sansure assay showed good traceability by agreeing with the HCV-1a WHO standard across all five concentrations tested (25, 50, 100, 1000, 10,000 IU/ml). The differences between observed average concentrations and expected concentrations were all within 0.2 log10 IU/ml. HCV WWHV303 standards across 4 HCV genotypes (1b, 2a, 3a and 6a) were used for evaluation of reproducibility and the accuracy of the test were all within 0.2 log10 IU/ml. The inter-assay variations across the above 4 HCV genotypes were all less than 0.03 on each evaluated concentration, indicating good precision of Sansure HCV RNA assay. In clinical practice, concordant results were determined in 99.42% (344/346) samples (215 positive and 129 negative samples). Two specimens with negative HCV RNA results by Sansure assay were detected positive by CAP/CTM HCV test. Correlation analysis indicated a significantly positive correlation in detected HCV RNA concentrations (r = 0.9439, P < 0.0001). HCV RNA levels in 95.35% (205/215) specimens were within mean difference ± 1.96 SD as tested by both assays.Conclusions: With the advantages of traceability, reproducibility and lower price, Sansure HCV RNA assay represented an alternative option for HCV RNA detection in hospital and medical institution in China. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
6. Liver Damage in Patients with HCV/HIV Coinfection Is Linked to HIV-Related Oxidative Stress.
- Author
-
Huang, Xiangbo, Liang, Hua, Fan, Xueying, Zhu, Liyan, and Shen, Tao
- Published
- 2016
- Full Text
- View/download PDF
7. Adsorption and fixation behaviour of CI Reactive Red 195 on cotton woven fabric in a nonionic surfactant Triton X-100 reverse micelle.
- Author
-
Yi, Shixiong, Dong, Yongchun, Li, Bing, Ding, Zhizhong, Huang, Xiangbo, and Xue, Lexing
- Subjects
COTTON textiles ,REACTIVE dyes ,COTTON dyeing ,LANGMUIR probes ,SALT ,MICELLES - Abstract
To achieve the goals of saving water and being salt-free in the coloration of cotton fabric with reactive dye, nonionic reverse micelles were prepared and optimised with a surfactant, Triton X-100, n-octanol and isooctane by injecting a small amount of CI Reactive Red 195 aqueous solution. The adsorption, diffusion and fixation of this dye on cotton fabric in Triton X-100 reverse micelle and bulk water were then investigated. The equilibrium and kinetic data of the dye adsorption process were evaluated. The colour strength and fixation rate of cotton fabrics dyed in the micelle and in bulk water were also examined and compared. The results indicated that the amount of dye adsorbed increased with the increasing temperature and the initial dye concentration. The dye adsorption process could be described using the Langmuir isotherm and pseudo-second-order kinetic equations. It was found that CI Reactive Red 195 showed a stronger adsorption property on cotton fabric in Triton X-100 reverse micelle than in bulk water without the addition of sodium chloride. Using Triton X-100 reverse micelle as the dyeing medium offered the reactive dye better diffusion performance within the cotton fibre as compared with bulk water. Moreover, higher fixation of the dyes absorbed on the cotton fibre was achieved when the optimum concentration of sodium carbonate was used as the alkali agent in Triton X-100 reverse micelle. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
8. Delivery of Cas9-guided ABE8e into stem cells using poly(l-lysine) polypeptides for correction of the hemophilia-associated FIX missense mutation.
- Author
-
Rong, Lijuan, Chen, Dandan, Huang, Xiangbo, and Sun, Ling
- Subjects
- *
STEM cells , *MISSENSE mutation , *POLYPEPTIDES , *BLOOD coagulation factor IX , *HEMOPHILIACS , *STAR-branched polymers , *BLOOD coagulation factors - Abstract
The coagulation factor 9 gene (FIX) point mutation contributes to most hemophilia B cases, providing ideal gene correction models. Here we identified the frequent mutation G20519A (R226Q) in FIX , which resulted in many severe and moderate hemophilia B patients. This study aimed to investigate the effect of HDR and base editing in correcting FIX mutant. We first constructed HEK293 and liver-derived cell lines Huh7 cells stabling carrying mutated FIX containing G20519A (HEK293-FIXmut and Huh7-FIXmut). Then, CRISPR/Cas9-based homology-directed repair (HDR) and base editing were used for the correction of this mutated point. We used Cas9 nickase (nCas9) mediated HDR and the advanced base editor ABE8e to correct G20519A and then measured the concentration and activity of FIX. Furthermore, we used the star-shaped poly(lysine) gene nanocarriers to deliver the ABE8e correction systems into HEK293-FIXmut and Huh7-FIXmut stem cells to correct mutated FIX. As a result, we found that gRNAs directed inefficient HDR in correcting G20519A. The ABE8e corrected the mutation efficiently in both HEK293-FIXmut and Huh7-FIXmut stem cells. In addition, the star-shaped poly(lysine) carriers delivered non-viral vectors into stem cells efficiently. The nanocarriers-delivered ABE8e system corrected mutated FIX in stem cells, and the stem cells secreted active FIX in high concentration. In conclusion, our study provides a potential alternative for correcting mutated FIX in hemophilia B patients. • The point mutation G20519A (R226Q) in FIX results to lower concentration and lower activity of FIX. • ABE8e corrected mutated FIX more efficiently compared with HDR. • Bioinspired star shaped PLL polypeptides could deliver gene correction systems into stem cells. • PLL-delivered ABE8e system could correct mutated FIX efficiently in stem cells. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Failure recovery of circulating NKG2D CD56 NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence.
- Author
-
Gao, Jian, Duan, Zhaojun, Huang, Xiangbo, Long, Lu, Tu, Jing, Shen, Tao, Lu, Fengmin, Zhang, Ling, Liang, Hua, and Zhang, Yu
- Subjects
KILLER cells ,HEPATITIS B virus ,CANCER relapse ,LIVER cancer ,HEPATECTOMY ,T cells ,THERAPEUTICS - Abstract
Dysfunction of natural killer (NK) cells has been implicated in the failure of antitumor immune responses in hepatocellular carcinoma (HCC) patients. However, the changes of NK profile in peripheral blood after surgery and tumor tissues of HCC patients, as well as the underlying reason and the significance are vague. Here, we observed that the frequencies of circulating NKG2D+CD56dimNK cells decreased significantly in HBV-related HCC and were negatively correlated with the levels of serum TGF-β and soluble MICA (sMICA).In vitroexperiments confirmed that the TGF-β and sMICA in tumor tissue homogenates, as well as sMICA in HCC cells culture supernatants could reduce the frequency of NKG2D+CD56dimNK cells. In addition, in HCC patients the lower frequency of circulating NKG2D+CD56dimNK cells was associated with larger tumor size and/or higher serum GGT. Noticeably, the frequency of NKG2D+CD56dimNK cells at one month after surgery usually failed to restore in early recurrent patients, and that frequency was negatively associated with early recurrence and shorter overall survival. These results suggest that declined frequency of NKG2D+CD56dimNK cells in HCC was associated with higher TGF-β and sMICA production, and low frequency of circulating NKG2D+CD56dimNK cells at one month after surgery may predict poor prognosis of HBV-related HCC patients accepting hepatectomy. [ABSTRACT FROM PUBLISHER]
- Published
- 2016
- Full Text
- View/download PDF
10. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound.
- Author
-
Wang, Jie, Shen, Tao, Huang, Xiangbo, Kumar, G. Renuka, Chen, Xiangmei, Zeng, Zhenzhen, Zhang, Ruiyang, Chen, Ran, Li, Tong, Zhang, Tianying, Yuan, Quan, Li, Pao-Chen, Huang, Qi, Colonno, Richard, Jia, Jidong, Hou, Jinlin, McCrae, Malcolm A., Gao, Zhiliang, Ren, Hong, and Xia, Ningshao
- Subjects
- *
HEPATITIS B virus , *CHRONIC hepatitis B , *ELECTRON microscopy , *NORTHERN blot , *POLYMERASE chain reaction , *DNA polymerases , *PATIENTS , *THERAPEUTICS - Abstract
Background & Aims Hepatitis B virus (HBV) RNA in serum has recently been linked to efficacy and prognosis of chronic hepatitis B (CHB) treatment. This study explored the nature, origin, underlying mechanisms, and potential clinical significance of serum HBV RNA. Methods The levels of HBV DNA and RNA were determined in the supernatant of induced HepAD38, HBV-expressing HepG2.2.15 cells and primary human hepatocytes (PHH), and in the serum of transgenic mice and CHB patients. NP-40 and proteinase K treatment, sucrose density gradient centrifugation, electron microscopy, northern blot, multiple identification PCRs and 5′ rapid-amplification of cDNA ends were performed to identify the nature of serum HBV RNA. Results Although significantly lower than HBV DNA levels, abundant HBV RNA was present in the serum of CHB patients. A series of experiments demonstrated that serum HBV RNA was pregenome RNA (pgRNA) and present in virus-like particles. HBV pgRNA virion levels increased after blocking the reverse transcription activity of HBV DNA polymerase, and decreased after blocking the encapsidation of pgRNA. Furthermore, the presence of HBV pgRNA virion was associated with risk of viral rebound after discontinuation of nucleot(s)ide analogues (NAs) therapy in CHB patients. Conclusions Serum HBV RNA was confirmed to be pgRNA present in virus-like particles. HBV pgRNA virions were produced from encapsidated particles in which the pgRNA was non- or partially reverse transcribed. Clinically, HBV pgRNA virion might be a potential biomarker for monitoring safe discontinuation of NA-therapy. Lay summary HBV may have another virion form in which the nucleic acid is composed of RNA, not DNA. The level of HBV RNA virion in serum may be associated with risk of HBV viral rebound after withdrawal of treatment, and therefore, a potential predictive biomarker to monitor the safe discontinuation of nucleot(s)ide analogues-therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.